Seminars in Hematology
Volume 40, Issue 3 , Pages 201-212, July 2003

Natural killer receptors in patients with lymphoproliferative diseases of granular lymphocytes

  • Renato Zambello

      Affiliations

    • Department of Clinical and Experimental Medicine, Clinical Immunology Branch, Padua University School of Medicine, Padua, Italy
  • ,
  • Gianpietro Semenzato

      Affiliations

    • *Address correspondence to Gianpietro Semenzato, MD, Università degli Studi di Padova, Dip. Medicina Clinica e Sperimentale, Immunologia Clinica, Via Giustiniani 2, Padova 35128, Italy
    • Department of Clinical and Experimental Medicine, Clinical Immunology Branch, Padua University School of Medicine, Padua, Italy

Abstract 

The most relevant criterion for recognizing chronic granular lymphocyte (GL) proliferations, defined as lymphoproliferative disease of GL (LDGL), has been historically based on the number of the proliferating cells displaying typical GL morphology. With the extensive development of immunological and molecular techniques, two major groups of LDGL have been recognized, one belonging to the T-cell and the other to the NK cell lineage. The recent definition of a series of receptors of NK cells (NKR) and the identification of the specific targets recognized has expanded our knowledge of the properties of these cells and the discrimination between functional reactive and pathological proliferations. Some of these receptors are expressed by GL of T-cell lineage, suggesting a possible involvement in the genesis of GL proliferation. Following an extensive description of NKR in humans, this review will summarize the recent data on phenotypic and functional characteristics of NKR expressed by proliferating GL in patients with LDGL, discussing their role in this disorder.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by grants awarded by Associazione Italiana per la Ricerca sul Cancro (AIRC), CNR, Ministero della Sanità, Ministero dell’Università e della Ricerca Scientifica e Tecnologica (MIUR), and Consiglio Nazionale delle Ricerche.

PII: S0037-1963(03)00134-3

Seminars in Hematology
Volume 40, Issue 3 , Pages 201-212, July 2003